Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
Equus caballus (horse)
| UniProt ID | Protein Name | Gene Symbol | No. of Glycosylation Sites | No. of GlyTouCan IDs | Disease Ontology |
|---|---|---|---|---|---|
| A0A3Q2HHA0 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
| P48770 | Complement component C9 |
|
3 | 0 |
|
| A0A5F5PQU7 | Peptidylglycine alpha-amidating monooxygenase |
|
1 | 0 |
|
| P08751 | Lutropin/choriogonadotropin subunit beta |
|
13 | 23 |
|
| A0A3Q2HRP7 | Phosphoinositide phospholipase C |
|
2 | 0 |
|
| F6YFJ5 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
| Q95LG1 | E-selectin |
|
9 | 0 |
|
| P42202 | Interleukin-4 |
|
2 | 0 |
|
| A0A9L0RX25 | Angiotensin-converting enzyme |
|
2 | 0 |
|
| Q3ZTK5 | Tumor necrosis factor receptor superfamily member 5 |
|
1 | 0 |
|
| F7B5T3 | Hyaluronidase |
|
1 | 0 |
|
| F6TM26 | Pannexin |
|
1 | 0 |
|
| A0A5F5PNY6 | Fibroblast growth factor receptor |
|
8 | 0 |
|
| O19011 | Transforming growth factor beta-1 proprotein |
|
3 | 0 |
|
| F6RLC0 | Hyaluronidase |
|
1 | 0 |
|
| F6YLN3 | ADAM metallopeptidase with thrombospondin type 1 motif 1 |
|
3 | 0 |
|
| Q2QLA6 | Suppressor of tumorigenicity 7 protein |
|
1 | 0 |
|
| A0A9L0S5M0 | Angiotensin-converting enzyme |
|
1 | 0 |
|
| A0A3Q2GTC5 | P2X purinoceptor |
|
1 | 0 |
|
| Q4AEE3 | Deoxyribonuclease-1 |
|
2 | 0 |
|
| F6RJ92 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
| A0A9L0RRL1 | Paraoxonase |
|
2 | 0 |
|
| A0A5F5PLB9 | GDNF family receptor alpha-2 |
|
2 | 0 |
|
| A0A3Q2GVK8 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
| A0A9L0TFJ0 | P2X purinoceptor |
|
1 | 0 |
|
